FindTrial
Sign In

Effects of Lidocaine patch application of pain s subjective and objective components in patients with Myofascial Pain Syndrome MPS .

Effects of Lidocaine patch application of pain s subjective and objective components in patients with Myofascial Pain Syndrome MPS .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2005-001661-34-IT
Enrollment
Unknown
Registered
2007-03-22
Start date
2005-07-12
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome MPS MedDRA version: 9.1 Level: LLT Classification code 10048780 Term: Myofascial pain syndrome

Interventions

Pharmaceutical Form: Poultice INN or Proposed INN: Lidocaine Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 700- Trade Name: MARCAINA 1F 10ML 5MG/ML Pharmaceutica

Sponsors

IBSA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026